Parkinson’s disease is a serious brain disorder that slowly worsens over time. It mainly affects movement and can cause shaking, muscle stiffness, slow movement, balance problems, and difficulty walking.
As the disease progresses, many people also experience speech problems, trouble swallowing, sleep disturbances, and changes in thinking and mood.
The condition develops because certain brain cells that produce dopamine gradually become damaged or die. Dopamine is an important chemical messenger that helps control movement and coordination. When dopamine levels fall, the brain can no longer properly manage smooth and balanced body movements.
Parkinson’s disease affects millions of people worldwide, especially older adults. Although scientists have learned a great deal about the disease, there is still no cure. Researchers continue searching for possible causes and risk factors in the hope of finding better ways to prevent or treat it.
Now, a new study from researchers at Queen Mary University of London has found a possible link between Parkinson’s disease and a group of medicines called antiepileptic drugs. These medicines are commonly used to treat epilepsy and other conditions involving unusual electrical activity in the brain.
Antiepileptic drugs help prevent seizures, which happen when brain signals become abnormal and uncontrolled. Seizures can range from brief episodes of staring to severe convulsions involving the whole body. For many people with epilepsy, these medications are essential and life-saving.
Some antiepileptic medicines are also prescribed for other medical conditions, including nerve pain, bipolar disorder, migraines, and mood disorders. Because these drugs are widely used, understanding their long-term effects is very important.
To explore whether there could be a connection between antiepileptic drugs and Parkinson’s disease, the researchers studied medical records from 1,433 people diagnosed with Parkinson’s disease. They compared these patients with 8,598 people who did not have the condition.
The scientists focused on prescriptions for several commonly used antiepileptic drugs. These included carbamazepine, lamotrigine, levetiracetam, and sodium valproate.
The results showed a concerning pattern. People who had taken antiepileptic drugs appeared to have a higher risk of developing Parkinson’s disease compared with people who had not used these medicines.
The researchers also found that the risk increased with greater exposure to the drugs. In simple terms, the more prescriptions a person had received, the higher their risk seemed to be. In addition, people who used more than one type of antiepileptic drug appeared to face an even greater risk.
This study is important because it is the first large investigation to examine several different antiepileptic medicines together and explore their possible connection to Parkinson’s disease.
Even though the findings are concerning, the researchers stressed that the study does not prove the medications directly cause Parkinson’s disease. The research only found an association, meaning the two factors appeared linked. More studies are needed to understand exactly why this relationship exists.
There may be several possible explanations. It is possible that the drugs themselves affect brain pathways related to movement and dopamine function.
Another possibility is that the underlying conditions requiring antiepileptic treatment could somehow contribute to Parkinson’s disease risk. Researchers say more work is needed to separate these possibilities.
The scientists hope future research will help explain how these medicines interact with the brain over long periods of time. Understanding these mechanisms may also provide new clues about what causes Parkinson’s disease in general.
Despite the findings, medical experts strongly warn patients not to stop taking antiepileptic medicines without speaking to a doctor first.
These medications are extremely important for controlling seizures, and suddenly stopping them can be dangerous. Uncontrolled seizures may lead to injuries, accidents, brain damage, or even death.
Doctors and patients should instead use the information from the study as part of ongoing discussions about treatment choices. In some situations, healthcare providers may decide to monitor patients more closely or consider alternative medications when appropriate.
The study also highlights the importance of carefully balancing the benefits and risks of long-term medication use. Many medicines that help one health condition can sometimes affect other parts of the body in unexpected ways. This is why ongoing medical research and safety monitoring are so important.
The researchers also emphasized that Parkinson’s disease likely develops from a combination of factors rather than a single cause. Genetics, environmental exposures, aging, lifestyle, and medical history may all work together to influence risk.
The research was led by Daniel Belete and published in the journal JAMA Neurology. Scientists believe the findings are an important step toward better understanding Parkinson’s disease and identifying factors that may contribute to its development.
As research continues, doctors may become better able to identify which patients are at higher risk and develop safer treatment strategies. In the future, these discoveries may help reduce the number of people affected by Parkinson’s disease and improve care for those already living with the condition.
If you care about Parkinson’s disease, please read studies that Vitamin B may slow down cognitive decline, and Mediterranean diet could help lower risk of Parkinson’s.
For more information about brain health, please see recent studies that blueberry supplements may prevent cognitive decline, and results showing Plant-based diets could protect cognitive health from air pollution.
Copyright © 2026 Knowridge Science Report. All rights reserved.
